MaxCyte (MXCT) Stock: Buy, Sell, or Hold?
MXCT - MaxCyte, Inc. Common Stock
$1.07
-0.02 (-1.83%)
▼
5d:
-8.55%
30d:
-15.75%
90d:
-15.75%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 11, 2026
Get Alerted When MXCT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: MXCT shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: MXCT shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: MXCT is currently trading at $1.07, which is considered oversold relative to its 30-day fair value range of $1.15 to $1.27.
Technical Outlook: Technically, MXCT is in a strong downtrend. The price is currently testing key support at $1.07. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 41/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $4.11 (+283.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MXCT is in a strong downtrend. The price is currently testing key support at $1.07. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 41/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $4.11 (+283.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.15 -
$1.27
Company Quality Score
36/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (41/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 283.9% below Wall St target ($4.11)
- WARNING: Composite score 36/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.15 -
$1.27
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.07
Resistance Level
$1.25
Current Trend
Strong Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.36
Wall Street Target
$4.11
(+283.9%)
Revenue Growth (YoY)
-14.5%
Profit Margin
-114.8%
Share & Embed Analysis
Last updated: October 03, 2026 10:18 PM ET
Data refreshes hourly during market hours. Next update: 11:18 PM
Data refreshes hourly during market hours. Next update: 11:18 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MXCT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$61 | 62 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$369 | 69 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 47 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 64 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 51 HOLD |
